Quantcast

Latest Quigley Pharma Stories

2008-11-14 09:00:34

Quigley Pharma, a wholly-owned subsidiary of The Quigley Corporation, has announced that the last subject in the Phase IIb study is scheduled to complete treatment on November 25, 2008. This will effectively move the study to the final stage of data collection, evaluation and study conclusions, the company said. The Phase IIb study is designed to evaluate the safety and efficacy of QR-333, a topical formulation designed to offer physicians and patients an effective, easy to administer, safe...


Word of the Day
holluschickie
  • A 'bachelor seal'; a young male seal which is prevented from mating by its herd's older males (mated bulls defending their territory).
This comes from the Russian word for 'bachelors.'
Related